Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 5.41 -5.75% -0.33
TENX closed down 5.75 percent on Friday, September 21, 2018, on 80 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical TENX trend table...

Date Alert Name Type % Chg
Sep 21 Inside Day Range Contraction 0.00%
Sep 20 Crossed Above 20 DMA Bullish -5.75%
Sep 20 Pocket Pivot Bullish Swing Setup -5.75%
Sep 20 Volume Surge Other -5.75%
Sep 19 Fell Below 20 DMA Bearish 7.98%
Sep 19 180 Bearish Setup Bearish Swing Setup 7.98%
Sep 19 Oversold Stochastic Weakness 7.98%
Sep 18 1,2,3 Retracement Bearish Bearish Swing Setup 0.19%
Sep 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.19%
Sep 18 Crossed Above 20 DMA Bullish 0.19%

Older signals for TENX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Is TENX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.63
52 Week Low 4.4
Average Volume 6,879
200-Day Moving Average 6.6906
50-Day Moving Average 5.8536
20-Day Moving Average 5.3785
10-Day Moving Average 5.215
Average True Range 0.4262
ADX 30.83
+DI 14.9937
-DI 16.8715
Chandelier Exit (Long, 3 ATRs ) 4.6714
Chandelier Exit (Short, 3 ATRs ) 6.2786
Upper Bollinger Band 5.896
Lower Bollinger Band 4.861
Percent B (%b) 0.53
BandWidth 19.243283
MACD Line -0.1274
MACD Signal Line -0.1772
MACD Histogram 0.0498
Fundamentals Value
Market Cap 152.77 Million
Num Shares 28.2 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -3.78
Price-to-Sales 0.00
Price-to-Book 1.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.97
Resistance 3 (R3) 6.02 5.88 5.87
Resistance 2 (R2) 5.88 5.74 5.86 5.84
Resistance 1 (R1) 5.65 5.65 5.58 5.60 5.81
Pivot Point 5.51 5.51 5.48 5.49 5.51
Support 1 (S1) 5.28 5.37 5.21 5.23 5.01
Support 2 (S2) 5.14 5.28 5.12 4.98
Support 3 (S3) 4.91 5.14 4.95
Support 4 (S4) 4.86